Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study.
D000328:Adult; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D004317:Doxorubicin; D005472:Fluorouracil